Format

Send to

Choose Destination
Heart. 2019 Apr;105(7):567-578. doi: 10.1136/heartjnl-2017-311213. Epub 2018 Oct 31.

Imaging as a surrogate marker of drug efficacy in cardiovascular disease.

Author information

1
Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
2
National Heart & Lung Institute, Hammersmith Hospital, Imperial College London, London, UK.
3
Centre for Cardiovascular Science, University of Edinburgh, Little France Crescent, Edinburgh, UK.

KEYWORDS:

cardiac imaging and diagnostics; coronary artery disease; positron emission tomographic (pet) imaging

PMID:
30381320
DOI:
10.1136/heartjnl-2017-311213
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center